← Leaderboards
Robert Kirwan Campbell
Boston University (Charles River Campus)
$1,276,871
Attributed
$2,553,741
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $617K · FY2009–13$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,553,741 · 1
By mechanism
R01$2,553,741 · 1
Top collaborators
- Michael P Pollastri8 shared
Most similar at Boston University (Charles River Campus)
Same institution · by research overlap
- Michael P Pollastri$8,526,266
Others in their field
Top investigators on “Validation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$515,091,456
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- David Heimbrook · Leidos Biomedical Research, Inc.$239,311,963
Research focus
ValidationPhosphodiesterase InhibitorsAdverse EffectsAfrican TrypanosomiasisAfrica South Of The SaharaAnimal ModelBiologicalCessation Of LifeBiological ProductsBiomedical ResearchBiteBlood - Brain Barrier AnatomyBlood CirculationBrainCellsBaseChagas DiseaseClinicClinical ResearchCollaborationsCommunicable DiseasesCommunitiesCompliance BehaviorAffect
Grant awards (8)
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$404,894
R01 · FY2013 · AI
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$457,655
R01 · FY2012 · AI
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$537,683
R01 · FY2011 · AI
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$536,539
R01 · FY2010 · AI
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$354,990
R01 · FY2009 · AI
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$196,147
R01 · FY2009 · AI
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$39,583
R01 · FY2009 · AI
Validation and development of trypanosomal phosphodiesterase inhibitors for treat$26,250
R01 · FY2009 · AI